Drugs / OSP:rTTHc Cholera Conjugate Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05559983 | Dec 2022 → Sep 2023 | — | International Vaccine Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OSP:rTTHc Cholera Conjugate Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05559983 ↗ |
| Modality | Vaccine | “OSP:rTTHc Cholera Conjugate Vaccine” NCT05559983 ↗ |
| Route | Intramuscular | “All the participants will receive two intramuscular injections of 0.5 mL of the designated study vaccine or placebo on deltoid muscle, on Days 0 and 28.” NCT05559983 ↗ |